Walleye Trading LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$131,307,000
-25.8%
5,650,057
-49.2%
0.71%
-30.2%
Q1 2018$176,995,000
+110.3%
11,117,780
+174.5%
1.02%
+148.2%
Q4 2017$84,152,000
+46.7%
4,049,900
+1.2%
0.41%
+44.5%
Q3 2017$57,362,000
+199.2%
4,003,422
+261.2%
0.28%
+141.9%
Q2 2017$19,174,000
+320.2%
1,108,470
+167.9%
0.12%
+265.6%
Q1 2017$4,563,000
-21.4%
413,693
+3.4%
0.03%
-22.0%
Q4 2016$5,805,000
-49.2%
400,100
-14.0%
0.04%
-44.6%
Q3 2016$11,416,000
+60.4%
465,223
+31.5%
0.07%
+54.2%
Q2 2016$7,119,000
-1.4%
353,829
+29.2%
0.05%
-25.0%
Q1 2016$7,219,000
-40.7%
273,901
+128.6%
0.06%
-45.8%
Q4 2015$12,176,000
-38.7%
119,800
+7.6%
0.12%
-35.2%
Q3 2015$19,852,000
-6.6%
111,300
+16.3%
0.18%
-13.7%
Q2 2015$21,259,000
+15.0%
95,700
+2.8%
0.21%
+14.1%
Q1 2015$18,493,000
-64.8%
93,100
-74.6%
0.18%
-61.1%
Q4 2014$52,550,000
+3005.8%
367,200
+2746.5%
0.48%
+2275.0%
Q3 2014$1,692,00012,9000.02%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2016
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,373,210$47,796,00039.06%
Claren Road Asset Management, LLC 77,527$1,561,00018.46%
Okumus Fund Management Ltd. 4,242,012$85,434,00014.79%
Chou Associates Management 1,446,843$29,139,00011.12%
FARLEY CAPITAL L.P. 307,458$6,192,0009.65%
HAP Trading, LLC 3,129,700$112,397,0006.58%
Pershing Square Capital Management 21,591,122$434,845,0005.79%
NORTH TIDE CAPITAL, LLC 2,500,000$50,350,0005.61%
Convector Capital Management, LP 192,000$3,867,0005.34%
Nebula Capital Management, LP 31,770$640,0005.07%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders